Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 12—December 2024
Research
Clinical Manifestations, Antifungal Drug Susceptibility, and Treatment Outcomes for Emerging Zoonotic Cutaneous Sporotrichosis, Thailand
Pattriya Jirawattanadon, Sumanas Bunyaratavej, Charussri Leeyaphan, Piriyaporn Chongtrakool, Panitta Sitthinamsuwan, Waratchaya Panjapakkul, Suthasanee Prasertsook, Phuwakorn Saengthong-aram, Nicha Wareesawetsuwan, Julaluck Posri, and Penvadee Pattanaprichakul
Table 2
Patient exposure to cats in study of clinical manifestations, antifungal drug susceptibility, and treatment outcomes for emerging zoonotic cutaneous sporotrichosis, Thailand*
| Patient exposures to cats | No. sporotrichosis cases/total (%) |
|---|---|
| Direct contact | 23/32 (71.9) |
| Being scratched or bitten | 22/23 (95.7) |
| Feeding | 16/23 (69.6) |
| Attending to cat wound |
4/23 (17.4) |
| Indirect contact† |
9/32 (28.1) |
| Types of cat socialization | |
| Owned, outdoor cat‡ | 27/32 (84.4) |
| Stray cat |
5/32 (15.6) |
| Exposed to cat with sporotrichosis diagnosis | 21/32 (65.6) |
*Patients could have >1 contact history. †Patients reported stray cats in the vicinity of their homes but indicated no direct contact. ‡Cats that have homes but can go outside.
Page created: September 24, 2024
Page updated: November 15, 2024
Page reviewed: November 15, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.